Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Jan 2026 | 31 Jan 2025 |
|---|---|---|
| Revenue | 172M | 123M |
| Cost of revenue | 129M | 93M |
| Gross profit | 43M | 31M |
| Research and development | 288,000 | 455,000 |
| Selling, general and administrative | 36M | 25M |
| Operating expenses | 36M | 26M |
| Operating income | 7M | 5M |
| Pre-tax income | 7M | 5M |
| Income tax | 2M | 995,000 |
| Net income | 5M | 4M |
| Earnings per share | 0.14 | 0.10 |
| Earnings per share, diluted | 0.13 | 0.09 |
| Weighted average shares | 39M | 37M |
| Weighted average shares, diluted | 41M | 39M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 24M | 20M | 18M | 9M | 12M | 7M | 9M | 7M |
| Receivables | 13M | 13M | 11M |
| Metric | 31 Jan 2026 | 31 Jan 2025 |
|---|---|---|
| Operating cash flow | 11M | 5M |
| Depreciation and amortisation | 3M | 2M |
| Share-based compensation | 2M | 1M |
| Capital expenditure | 2M | 5M |
| Investing cash flow | −19M | −5M |
| Financing cash flow | 20M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 7M |
| 6M |
| 8M |
| 9M |
| 8M |
| Inventory | 9M | 10M | 10M | 6M | 5M | 5M | 3M | 3M |
| Current assets | 49M | 45M | 41M | 23M | 24M | 22M | 22M | 20M |
| Goodwill | 9M | 9M | 9M | 9M | 9M | 9M | 9M | 9M |
| Total assets | 88M | 86M | 84M | 51M | 53M | 47M | 48M | 43M |
| Current liabilities | 21M | 21M | 22M | 15M | 19M | 17M | 19M | 14M |
| Total liabilities | 32M | 33M | 34M | 22M | 26M | 22M | 25M | 21M |
| Equity | 55M | 53M | 50M | 30M | 26M | 25M | 23M | 22M |
| Shares outstanding | 41M | 41M | 41M | 38M | 38M | 38M | 38M | 37M |
| Shares issued | 41M | 41M | 41M | 38M | 38M | 38M | 38M | 38M |
| Treasury shares | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 | 230,000 |
| −4M |